The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: Comparison between women with PCOS and normal ovulatory women

Molecular Human Reproduction

Volumn 7, Issue 4, 2001, Pages 325-331

  Shalev, Eliezer ^a,b   Goldman, Shlomit ^a   Ben Shlomo, Izhar ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Luteinized granulosa cells; MMP; Polycystic ovarian syndrome; TIMP

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; HUMAN CELL; LUTEINIZATION; OVARY; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; PROTEIN SECRETION; STIMULATION;

MAMMALIA;

EID: 0035071166     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/7.4.325     Document Type: Article

References (35)

1. The effects of dehydroepiandrosterone (DHEA) and its metabolites on the polycystic ovarian condition (PCO): Cystogenic changes of rat granulosa cells in vitro
2. The polycystic ovarian (PCO) condition: Apoptosis and epithelialization dehydroepiandrosterone (DHEA)-treated rat model
3. Effect of gonadotrophin on cell and matrix retention and expression of metalloproteinases and their inhibitor in cultured human granulosa cells modelling corpus luteum function
4. Differential distribution of gelatinases and tissue inhibitor of metalloproteinase-1 in the rat ovary
5. Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients
6. Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome
7. Individual implantation rate: Proposal for a new index for evaluation of assisted reproduction results
8. Hyperandrogenic anovulation (the polycystic ovary syndrome) back to the ovary?
9. Matrix metalloproteinases: A review
10. Correlation of hyperandrogen with hyperinsulinisim in polycystic ovarian disease
11. Oocyte quality in polycystic ovaries revisited: Identification of a particular subgroup of women
12. Identification of MMP-18 a putative novel human matrix metalloproteinase
13. Granulosa cells of polycystic ovaries: Are they normal or abnormal?
14. Triiodothyronine and follicle-stimulating hormone, alone and additively together, stimulate production of the tissue inhibitor of metalloproteinase-1 (TIMP-1) in cultured human luteinized granulosa cells
15. Stimulation of matrix-metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression in rats by the preovulatory prolactin peak
16. Changes in extracellular matrix components and steroidogenic enzymes during growth and atresia of antral ovarian follicles in the sheep
17. Matrix metalloproteinases as mediators of reproductive function
18. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells
19. Ultrasound diagnosis of polycystic ovary syndrome
20. Coordinated and cell-specific regulation of membrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matrix metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation
21. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during the rat corpus luteum
22. Assessment of the role of tissue inhibitor of metalloproteinase 1 during the preovulatory period in female mice lacking a functional TIMP-1 gene
23. Immunohistochemical localization of renin and angiotensin in the rat ovary: Comparison between normal women and patients with histological proven polycystic ovarian disease
24. Secretion and gene expression of metalloproteinase and gene expression of their inhibitors in porcine corpora lutea at different stages of the luteal phase
25. Complex roles of matrix metalloproteinases in tumor progression
26. Characterization and hormonal regulation of a rat ovarian insulin-like growth factor binding protein-5 endopeptidase: An FSH-inducible granulosa cell-derived metalloprotease
27. Expression of 72 kDa and 92 kDa type IV collagenases from human giant cell tumor of bone
28. Production of matrix metalloproteinase-1 (interstitial collagenase) and matrix metalloprotease 2 (gelatinase A; 72 kDa gelatinase) by bovine endometrial cells in vitro: Different regulation and preferential fibroblasts
29. Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: A prospective study
30. Suppression of matrix metalloproteinase production by hCG in cultures of human luteinized granulosa cells as a model for gonadotropin-induced luteal rescue
31. hCG treated rabbit ovary
32. Ovulation as a tissue remodelling process. Proteolysis and cumulus expansion
33. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: Prospective study in 50 women
34. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor
35. Bovine granulosa cells express extracellular matrix proteins and their regulators during luteinization in culture